Manju Saxena

Dr. Manju Saxena is the Vice President of Product Development, and oversees the company’s process and analytical development activities for cell therapy program. Dr. Saxena is a scientific leader with over 30 years of experience directing projects from discovery to development in the areas of oncology, metabolic, immune disorders, and infectious diseases. Prior to joining NantKwest, she managed discovery and bioanalytical projects at Intertek’s Immunochemistry Centre of Excellence, Tandem labs, Amylin Pharmaceuticals, and Kirin Pharma USA. She has authored more than 50 peer reviewed articles and book chapters. Dr. Saxena received M.Phil and Ph.D. from University of Delhi.